Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Interest Coverage Ratio (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Interest Coverage Ratio for 12 consecutive years, with 67.55 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio fell 1977.84% year-over-year to 67.55, compared with a TTM value of 17.2 through Dec 2025, down 201.82%, and an annual FY2025 reading of 17.2, down 201.82% over the prior year.
  • Interest Coverage Ratio was 67.55 for Q4 2025 at Abvc Biopharma, down from 63.45 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 28.18 in Q4 2021 and bottomed at 357.48 in Q2 2021.
  • Average Interest Coverage Ratio over 5 years is 72.14, with a median of 18.43 recorded in 2023.
  • Peak annual rise in Interest Coverage Ratio hit 167.78% in 2021, while the deepest fall reached 7507.45% in 2021.
  • Year by year, Interest Coverage Ratio stood at 28.18 in 2021, then tumbled by 182.69% to 23.3 in 2022, then skyrocketed by 128.76% to 6.7 in 2023, then crashed by 148.51% to 3.25 in 2024, then tumbled by 1977.84% to 67.55 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ABVC at 67.55 in Q4 2025, 63.45 in Q3 2025, and 17.73 in Q2 2025.